FDA Finalizes Psychedelic Drug Guidance: What Sponsors Need to Know Expert Insights

FDA Finalizes Psychedelic Drug Guidance: What Sponsors Need to Know

In July 2026, the U.S. Food and Drug Administration (FDA) issued its final guidance, Psychedelic…

Hayley BellAugust 19, 2026

Hybrid and Decentralized CNS Clinical Trials: Finding the Right Balance Expert Insights

Hybrid and Decentralized CNS Clinical Trials: Finding the Right Balance

Key Takeaways: Both decentralized clinical trial (DCT) and hybrid models can be viable in CNS…

Hayley BellAugust 18, 2026

Built for Bold: CNS Clinical Trial Management Expert InsightsInside CRC

Built for Bold: CNS Clinical Trial Management

One of the first lessons CNS clinical trial management teaches you is that what works…

Hayley BellJuly 13, 2026

Tom Zoda, Ph.D., Chairs ASCP 2026 Panel on Preventable Failure Risk in CNS Clinical Trials Breaking News

Tom Zoda, Ph.D., Chairs ASCP 2026 Panel on Preventable Failure Risk in CNS Clinical Trials

ST. PETERSBURG, Fla., June 3, 2026 /PRNewswire/ -- Cognitive Research Corporation (CRC) Chief Executive Officer…

cogres1June 3, 2026

Why Driving Impairment Evaluation Is Becoming More Important in CNS Drug Development Expert Insights

Why Driving Impairment Evaluation Is Becoming More Important in CNS Drug Development

Key takeaways from the 2026 Lifesavers Conference on FDA driving guidance and functional safety assessment…

cogres1May 26, 2026

Research Rising: Clinical Trials Day 2026 Inside CRC

Research Rising: Clinical Trials Day 2026

Clinical Trials Day recognizes the people who make clinical research possible. In CNS drug development,…

cogres1May 20, 2026

Accelerating Psychedelic Therapeutics: A Regulatory Inflection Point in Mental Health Expert Insights

Accelerating Psychedelic Therapeutics: A Regulatory Inflection Point in Mental Health

In April 2026, a historic executive order “Accelerating Medical Treatments for Serious Mental Illness” was…

cogres1May 12, 2026

Connect with CRC at ASCP 2026 Conferences & Events

Connect with CRC at ASCP 2026

The American Society of Clinical Psychopharmacology (ASCP) annual meeting brings together leaders from academia, regulatory…

Morgan EdwardsApril 20, 2026

CRC’s Chief Scientific Officer, Gary Kay, Ph.D., to Speak at 2026 Lifesavers Conference on Roadway Safety Breaking News

CRC’s Chief Scientific Officer, Gary Kay, Ph.D., to Speak at 2026 Lifesavers Conference on Roadway Safety

ST. PETERSBURG, Fla., April 15, 2026 /PRNewswire/ -- Cognitive Research Corporation (CRC), a neuroscience-focused contract…

cogres1April 15, 2026

CNS Breakthroughs Favor the Bold: Marking 20 Years of Bold Research Inside CRC

CNS Breakthroughs Favor the Bold: Marking 20 Years of Bold Research

In CNS, breakthroughs do not come easily. They require total dedication to the science, the…

cogres1April 9, 2026

Extending Clinical Trials into Residential Care Facilities Expert Insights

Extending Clinical Trials into Residential Care Facilities

What It Takes to Build Research-Ready Networks in Long-term Care Facilities Clinical research has traditionally…

cogres1March 19, 2026

Connect with CRC at SIRS 2026 Conferences & Events

Connect with CRC at SIRS 2026

The Schizophrenia International Research Society (SIRS) Annual Congress is a global forum dedicated exclusively to…

cogres1March 17, 2026